1/18
Comprehensive vocabulary flashcards covering the pathophysiology, clinical etiologies, diagnostic criteria, and echocardiographic assessment of restrictive cardiomyopathy and cardiac amyloidosis.
Restrictive Cardiomyopathy (RCM)
A group of myocardial disorders characterized by stiff, rigid, and non-compliant ventricular walls that impair ventricular filling and diastolic function while preserving systolic ejection fraction until late stages of the disease.
Amyloidosis (in RCM)
The most common infiltrative etiology of restrictive cardiomyopathy, caused by the extracellular deposition of insoluble amyloid protein fibrils within the myocardium.
Endomyocardial Fibrosis
An endomyocardial disorder and major cause of restrictive cardiomyopathy characterized by fibrotic scarring lining the endocardium, leading to abnormal segmental wall motion and cavity obliteration.
HFpEF (Heart Failure with Preserved Ejection Fraction)
A clinical syndrome of heart failure where left ventricular ejection fraction remains preserved despite significant diastolic dysfunction, non-compliant ventricles, and elevated intracardiac filling pressures.
Ground Glass Appearance
An echocardiographic feature of the myocardium characterized by increased echogenicity and a sparkling, hyperrefractile granular texture, commonly observed in cardiac amyloidosis.

Apical Sparing Pattern
A distinctive global longitudinal strain (GLS) bull's-eye pattern characteristic of cardiac amyloidosis, marked by preserved longitudinal strain at the LV apex alongside severely reduced strain in the mid and basal segments ('cherry-on-top' appearance).
Rule of 5 (5-5-5)
An echocardiographic tissue Doppler indicator strongly suggestive of advanced cardiac amyloidosis, defined by mitral annular e′, a′, and s′ velocities all measuring <5cm/s.
Clinical Red Flags for Cardiac Amyloidosis
Extracardiac manifestations that raise clinical suspicion for systemic amyloidosis, including bilateral carpal tunnel syndrome, lumbar spinal stenosis, periorbital purpura, nephrotic syndrome, peripheral or autonomic neuropathy, unexplained weight loss, and heart failure.
Grade III Diastolic Dysfunction (Restrictive Filling Pattern)
An advanced diastolic filling abnormality characterized by a transmitral E/A ratio≥2.0, deceleration time <160ms, isovolumic relaxation time (IVRT) ≤70ms, average E/e′≥14, and pulmonary venous diastolic (D) wave predominance.
Mitral Inflow E/A Ratio
The ratio between the peak early diastolic transmitral filling velocity (E) and late atrial filling velocity (A); normally 0.8–2.0, decreasing to <0.8 in impaired relaxation and rising to >2.0 in restrictive filling.
Mitral Deceleration Time (DT)
The time elapsed from the peak of the transmitral E wave to the extrapolation of its downslope to baseline; normally 160–240ms, and significantly shortened (<160ms) in restrictive cardiomyopathy due to abrupt early pressure equalization between the left atrium and a non-compliant left ventricle.
Pulmonary Vein D-Wave Predominance
A pulmonary venous pulsed-wave Doppler profile where diastolic forward flow (D wave) exceeds systolic forward flow (S wave), reflecting high left atrial pressures and poor left ventricular compliance.

Left Atrial Volume Index (LAVI)
An echocardiographic measurement assessing left atrial volume indexed to body surface area via biplane area-length calculations; normal is 16–34mL/m2, with values >34mL/m2 indicating chronic elevation of left-sided filling pressures.
Low QRS Voltage Discordance
A diagnostic hallmark of cardiac amyloidosis defined by low-amplitude QRS complexes on an electrocardiogram despite significant pseudo-hypertrophy and increased left ventricular wall thickness (>1.2cm) on 2D echocardiography.

Fabry Disease
A rare X-linked lysosomal storage disorder caused by alpha-galactosidase A deficiency that leads to intracellular glycosphingolipid accumulation and a distinctive hyper-refractile subendocardial border on echocardiography.
Pseudoxanthoma Elasticum
A genetic disorder causing fragmentation and mineralization of elastic fibers in connective tissues and cardiovascular blood vessels, serving as an etiology of non-infiltrative restrictive cardiomyopathy.
Gaucher Disease
A sphingolipidosis storage disorder characterized by the metabolic inability to adequately degrade the lipid glucocerebroside, causing its pathologic accumulation within body tissues.
Pulmonary Artery Systolic Pressure (PASP)
A hemodynamic estimate calculated from Doppler tricuspid regurgitant velocity using the modified Bernoulli equation: PASP=4×(TR Vmax)2+RAP, where values >35mmHg suggest secondary pulmonary hypertension.
L Wave
A mid-diastolic forward transmitral inflow velocity wave appearing between the E wave and A wave on pulsed-wave Doppler, indicating significantly elevated left ventricular filling pressures.